Chamber and committees

Covid-19 was the highest single cause of excess mortality during summer 2021. Every one of these deaths is a tragedy. All those affected by the virus have our sympathy and we are working to prevent others from experiencing that same heartbreak.

As a result of the Scottish Government’s vaccination programme and increased medical knowledge of the virus, in summer 2021 the mortality rate was far lower, despite greater transmission of the virus. We are now offering boosters to protect the population further.

We are also working to remobilise our NHS safely and will be providing over £300 million in a winter funding package to support the health of people across Scotland this winter.

I have asked Teresa Medhurst, Interim Chief Executive of the Scottish Prison Service (SPS), to respond. Her response is as follows:

The SPS does not hold the requested data. Since 2013, SPS has asked all persons on admission to custody to self-declare any known disability. The response is recorded on SPS’ internal system as either: yes, no or prefer not to disclose. However, the type of disability it is not specifically recorded.

Every individual in SPS custody is interviewed by a Healthcare Professional on admission in order to assess their healthcare needs. Where there is an identified need for additional support or reasonable adjustments whilst in custody, SPS, NHS and our education service partners will work in partnership to facilitate this.

We anticipate that the long COVID Support Fund will be allocated over the next three financial years, providing Boards with additional resource to respond in a flexible and tailored manner to the needs of people with long COVID.

Our 2021-22 Budget takes the total health portfolio funding to in excess of £16 billion, with a further £1.9 billion of funding to address pressures related to COVID-19. This substantial additional investment is already benefiting a range of NHS services which are supporting the needs of people living with long COVID.

NHS Boards are expected to ensure that patients, including those living with severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) have access to a range of professionals to provide the appropriate management of their condition. We would further expect clinicians to have good awareness of guidance relevant to their practice area and apply these taking account of individual circumstances and discussions with the patient.

In light of the final National Institute for Health and Care Excellence (NICE) guideline for ME/CFS being published, we are considering how best to review and update existing Scottish guidance, and will be reviewing the need for specialist services as part of this work.

We are regularly engaging with our stakeholders, including the third sector, people with lived experience and clinicians working in this area, to drive forward care and the development of pathways. We plan to undertake a structured programme of stakeholder engagement in early 2022 to initiate the revision of Scottish guidance and to identify opportunities for improvement.

We have recently supported the creation of a Priority Setting Partnership by the James Lind Alliance and Action for M.E. to agree the top 10 priorities for future research on ME/CFS. This approach brings patients, carers and clinicians together to identify and prioritise research uncertainties in the field of ME/CFS, before disseminating the results to research funders.

We are investing £4.5 million of funding to implement the Neurological Care and Support Framework. Commitment 13 of the Neurological Care and Support Framework involves supporting neurological research, and we welcome proposals for ME/CFS research.

I refer the member to the answer to question S6W-04189 on 22 November 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

We are investing £4.5 million of funding to implement the Neurological Care and Support Framework. Through the framework, we have funded Action for ME to produce an online CPD learning module on ME/CFS for GPs and health professionals in Scotland, which aims to support person-centred care, informed by good practice and current research. In June 2021, officials presented the module to the Scottish Deans Medical Education Group, who agreed to consider introducing into medical school curriculums.

We are also liaising with NHS Education Scotland who have committed to producing a Practice-Based Small Group Learning module on ME/CFS following publication of the final National Institute for Health and Care Excellence (NICE) guidelines, and we understand that this work is now underway.

The additional £40 million for the culture sector was announced in light of the consequential funding expected from the £300 million uplift to the Culture Recovery Fund in March 2021 UK Budget. The Scottish Government has so far only received £9 million of these consequentials. We are still seeking clarity from HM Treasury on why the £40 million has not yet been passed on in full to us and are continuing to press the UK Government to deliver the remaining £31 million.

Despite only receiving to date £9 million of the consequentials, we have made available £25 million to support recovery in the culture sector, principally through the Cultural Organisations and Venues Recovery Fund (COVRF) and the Performing Arts Venues Relief Fund (PAVRF). £17.2 million has been awarded to performing arts venues and culture organisations via Creative Scotland. £1.25m has also been announced for funding for the Public Library Covid Relief Fund. This leaves £6.55m remaining to be allocated, £2m of which is capital. We are working with the culture sector to understand ongoing needs, and announcements on the final allocations will be made in the coming weeks.

I refer the member to the answer to question S6W-04189 on 22 November 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

The Woods In and Around Towns (WIAT) programme provides support to expand and sustainably manage Scotland’s urban woodlands while encouraging people to use and enjoy them. The programme supports activities in socially deprived communities and contributes to improving people’s health and well-being, sequestering carbon and helping our urban communities adapt to a changing climate.

The programme facilitates collaboration between local authorities, the private and the community sector to deliver initiatives ranging from the Central Scotland Green Network, Clyde Climate Forest and recent Lost Woods Project that provided the opportunity for children from all of Glasgow’s primary schools to take part in a mass tree planting scheme.

Under the current Forestry Grant Scheme the average annual funding available for the improvement and management of existing urban woodland is £750,000-£900,000 and for the creation of new woodland in areas covered by the Central Scotland Green Network, which is a focus area for the programme, is £8 million.

The total value of approved projects under these grants is:

The Scottish Government has commissioned a study from the Plant Health Centre on the implications of gene editing for plant health, including environmental impacts.

The Scottish Government has access to a wealth of expertise in its advisors, including the Chief Scientific Advisor for Environment, Natural Resources and Agriculture, who follow the latest scientific evidence and are qualified to comment on the environmental impact of gene editing.